JAMIE THERIAULT: Open Payments
NPI 1063996809 · WESTBROOK, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 26 payments from 13 companies in 2025. Trend: 2023 $113 · 2024 $256 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $79 |
| Daiichi Sankyo Inc. | 3 | $72 |
| ADC THERAPEUTICS AMERICA, INC. | 3 | $56 |
| Incyte Corporation | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 2 | $54 |
| Merck Sharp & Dohme LLC | 3 | $50 |
| PFIZER INC. | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Caris MPI, Inc. | 2 | $33 |
| GENZYME CORPORATION | 1 | $26 |
Products named: ERLEADA, ZYNLONTA, Enhertu, Vanflyta, XTANDI, MI CANCER SEEK, KEYTRUDA, NIKTIMVO.
Industry payments across ME — which companies pay providers there.
